Screener
Cyclerion Therapeutics CYCN Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
Revenue$100.0KIn line
EPS-$0.19Beat by $0.19
Revenue estimate$100.0K
EPS estimate-$0.38
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$900.0K
EPS estimate-$6.00
Versus estimates
Revenue
Diluted EPS
Q2 2026-$0.41Beat by $6.69Q1 2026-$0.76Beat by $16.44
Q4 2025-$0.19Beat by $0.19
Q1 2024-$0.38In lineQ3 2025-$0.30Q2 2025-$0.11FAQ
- When did Cyclerion Therapeutics report Q4 2025 earnings?
- Cyclerion Therapeutics (CYCN) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were Cyclerion Therapeutics's Q4 2025 revenue and EPS?
- Cyclerion Therapeutics reported revenue of $100.0K and eps of $-0.19 for Q4 2025.
- Did Cyclerion Therapeutics beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $100.0K by -. EPS beat the consensus estimate of $-0.38 by $0.19.
- How did Cyclerion Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 94.5% from $1.8M a year earlier.
- Where can I find Cyclerion Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-137909) and the 10-K periodic report (0001193125-26-132193) directly on SEC EDGAR. The filing index links above go to sec.gov.
